Cite
HARVARD Citation
Sfriso, P. et al. (2020). Canakinumab for the treatment of adult-onset Still's disease. Expert review of clinical immunology. pp. 129-138. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sfriso, P. et al. (2020). Canakinumab for the treatment of adult-onset Still's disease. Expert review of clinical immunology. pp. 129-138. [Online].